Published in Clin Exp Immunol on February 01, 2005
WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function. Blood (2008) 1.65
Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis. Blood (2008) 1.35
Wiskott-Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation. Immunobiology (2009) 1.32
Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol (2012) 1.27
Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombination. J Exp Med (2011) 1.24
Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans. J Autoimmun (2013) 1.07
Pathogenesis of autoimmunity in common variable immunodeficiency. Front Immunol (2012) 1.00
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency. Front Immunol (2012) 0.97
Molecular and phenotypic abnormalities of B lymphocytes in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol (2013) 0.95
Next generation sequencing reveals skewing of the T and B cell receptor repertoires in patients with wiskott-Aldrich syndrome. Front Immunol (2014) 0.92
Actin cytoskeletal defects in immunodeficiency. Immunol Rev (2013) 0.90
The actin-bundling protein L-plastin supports T-cell motility and activation. Immunol Rev (2013) 0.89
B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol (2015) 0.86
Intrinsic T- and B-cell defects impair T-cell-dependent antibody responses in mice lacking the actin-bundling protein L-plastin. Eur J Immunol (2013) 0.81
Wiskott-Aldrich syndrome: another piece in the puzzle. Clin Exp Immunol (2005) 0.76
Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol (1999) 5.98
Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics (1954) 5.36
Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr (1997) 3.80
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med (2003) 3.64
Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity (1998) 2.92
Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med (1999) 2.81
Peripheral development of B cells in mouse and man. Immunol Rev (2004) 2.74
HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci U S A (2001) 2.54
Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol (1996) 2.51
Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity (1996) 2.29
B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol (1997) 2.29
CD27: a memory B-cell marker. Immunol Today (2000) 2.24
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol (2000) 1.95
The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 1.91
A critical role for complement in maintenance of self-tolerance. Immunity (1998) 1.90
The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity (2003) 1.81
WASp in immune-system organization and function. Nat Rev Immunol (2002) 1.67
T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol (1993) 1.59
Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum (1986) 1.41
Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med (1979) 1.41
Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J Immunol (1997) 1.39
Human marginal-zone B cells. Immunol Today (1998) 1.31
Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology (1988) 1.30
Cdc42, Rac1, and the Wiskott-Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes. Blood (2001) 1.26
The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol (1990) 1.25
Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol (2003) 1.20
Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol (2004) 1.13
Defects in Wiskott-Aldrich syndrome blood cells. Blood (1996) 1.12
Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. J Clin Invest (1992) 1.08
Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome. J Pathol (1998) 0.98
The spleen in the Wiskott-Aldrich syndrome: histopathologic abnormalities of the white pulp correlate with the clinical phenotype of the disease. Am J Surg Pathol (1999) 0.96
The increase of non-MHC-restricted cytotoxic cells (gamma/delta-TCR-bearing T cells or NK cells) and the abnormal differentiation of B cells in Wiskott-Aldrich syndrome. Clin Immunol Immunopathol (1989) 0.95
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1995) 0.94
HIV disease in children is associated with a selective decrease in CD23+ and CD62L+ B cells. Clin Immunol Immunopathol (1996) 0.93
Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation. J Immunol (1987) 0.93
WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction. J Immunol (1999) 0.91
Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome. J Immunol (1994) 0.86
Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J Immunol (1998) 0.85
Multiple antigens are altered on T and B lymphocytes from peripheral blood and spleen of patients with Wiskott-Aldrich syndrome. Clin Exp Immunol (1996) 0.82
Recent advances in our understanding of Wiskott-Aldrich syndrome. Curr Opin Hematol (1999) 0.79
Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection. Clin Immunol Immunopathol (1995) 0.77
The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med (1969) 4.96
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81
Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest (1967) 4.45
Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med (1996) 3.89
Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69
AIDS--an immunologic reevaluation. N Engl J Med (1984) 3.53
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 3.32
Aberrations of suppressor T cells in human graft-versus-host disease. N Engl J Med (1979) 3.10
Homozygous deficiency of C3 in a patient with repeated infections. Lancet (1972) 3.04
The gamma globulins. 3. The antibody deficiency syndromes. N Engl J Med (1966) 3.03
Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest (1970) 2.92
Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity (1998) 2.92
N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility. Nat Cell Biol (2001) 2.91
Deficiency of C3 inactivator in man. J Immunol (1971) 2.86
Inactivator of the third component of complement as an inhibitor in the properdin pathway. Proc Natl Acad Sci U S A (1972) 2.84
Heterogeneity of "acquired" or common variable agammaglobulinemia. N Engl J Med (1974) 2.69
The opsonic fragment of the third component of human complement (C3). J Exp Med (1975) 2.51
Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol (1996) 2.51
Abnormalities of immunoregulatory T cells in disorders of immune function. N Engl J Med (1979) 2.48
Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections. N Engl J Med (1982) 2.47
Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome). Lancet (1968) 2.40
Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med (1975) 2.35
Hereditary deficiency of the second component of complement (C'2) in man. J Clin Invest (1966) 2.32
Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide. J Exp Med (1973) 2.25
Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr Biol (2000) 2.19
Hereditary deficiency of the second component of complement (C2) in man: correlation of C2 haemolytic activity with immunochemical measurements of C2 protein. Immunology (1970) 2.17
Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3. N Engl J Med (1973) 2.17
Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med (1970) 2.08
The interaction between human monocytes and red cells. Specificity for IgG subclasses and IgG fragments. J Exp Med (1970) 2.05
Identification and characterization of subpopulations of lymphocytes in human peripheral blood after fractionation on discontinuous gradients of albumin. The cellular defect in X-linked agammaglobulinemia. J Clin Invest (1973) 2.05
Hereditary deficiency of the second component of complement (C'2) in man: further observations on a second kindred. J Immunol (1967) 1.98
Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med (1977) 1.85
Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. J Clin Invest (1971) 1.83
Selective gamma-g globulin deficiencies in patients with recurrent pyogenic infections. N Engl J Med (1970) 1.80
Hereditary angioneurotic edema: a clinical survey. Pediatrics (1966) 1.75
The primary immunodeficiencies (1). N Engl J Med (1984) 1.74
Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A (1989) 1.73
Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med (1984) 1.68
Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome. Blood (1987) 1.64
Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome. J Clin Invest (1981) 1.63
Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc Natl Acad Sci U S A (1996) 1.62
Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation. J Exp Med (1987) 1.61
CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature (1991) 1.60
Characterization of human antibody to polyribophosphate, the capsular antigen of Hemophilus influenzae, type B. Clin Immunol Immunopathol (1973) 1.60
T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol (1993) 1.59
Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science (1998) 1.59
Congenital cardiovascular disease and anomalies of the third and fourth pharyngeal pouch. Circulation (1972) 1.57
Inherited deficiency of the third component of human complement (C'3). J Clin Invest (1969) 1.56
Pathological events in platelets of Wiskott-Aldrich syndrome patients. Br J Haematol (1999) 1.53
Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. Blood (1986) 1.53
Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J Immunol (1997) 1.52
Genetic aspects of the complement system. Adv Immunol (1971) 1.52
A monoclonal antibody to sialophorin (CD43) induces homotypic adhesion and activation of human monocytes. J Exp Med (1989) 1.51
Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders. J Clin Invest (1981) 1.50
Congenital aplasia of the thymus gland (DiGeorge's syndrome). N Engl J Med (1968) 1.49
Mapping of the X-linked agammaglobulinemia locus by use of restriction fragment-length polymorphism. J Clin Invest (1986) 1.49
Beta-1C-globulin: metabolism in glomerulonephritis. Science (1966) 1.45
Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci U S A (1982) 1.44
Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med (1972) 1.44
The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b). J Exp Med (1975) 1.43
The primary immunodeficiencies. (2). N Engl J Med (1984) 1.43
The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization. Annu Rev Immunol (1999) 1.42
Cellular reactivity to Candida albicans antigen. N Engl J Med (1966) 1.41
The gamma globulins. 3. The antibody deficiency syndromes. N Engl J Med (1966) 1.40
Classification of the primary immune deficiencies: WHO recommendation. N Engl J Med (1970) 1.39
Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med (1978) 1.35
In vitro lymphocyte response of patients with immunologic deficiency diseases. N Engl J Med (1970) 1.34
Heterogeneity of nephritic factor and its identification as an immunoglobulin. Proc Natl Acad Sci U S A (1977) 1.34
Purification and chemical composition of gpL115, the human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Biol Chem (1986) 1.33
Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome. Lancet (1982) 1.33
Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man. Am J Pathol (1970) 1.32
Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema. J Clin Invest (1968) 1.32
Complement deficiencies. Annu Rev Immunol (1992) 1.30
Opsonic activity in the newborn: role of properdin. Pediatrics (1973) 1.30
Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins. N Engl J Med (1985) 1.30
A specific circulating antigen in hamsters infected with Schistosoma mansoni. Detection of antigen in serum and urine, and correlation between antigenic concentration and worm burden. Am J Trop Med Hyg (1969) 1.30
Classification of primary immunodeficiencies. N Engl J Med (1973) 1.28
Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization. J Clin Invest (1969) 1.27
Linkages of innate and adaptive immunity. Curr Opin Immunol (1998) 1.27
Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med (1970) 1.27
Biosynthetic defect in monocytes from human beings with genetic deficiency of the second component of complement. N Engl J Med (1975) 1.27
Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest (1983) 1.26
Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans. J Clin Invest (1977) 1.26
Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients. J Clin Invest (1981) 1.25
The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry (2001) 1.25
T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med (1992) 1.24
Moesin, the major ERM protein of lymphocytes and platelets, differs from ezrin in its insensitivity to calpain. FEBS Lett (1999) 1.24
Deficiency of T helper cells in transient hypogammaglobulinemia of infancy. N Engl J Med (1981) 1.23